The 20th Annual State-of-the-Art Echo Course has been developed to review society guidelines for evaluation of cardiac structure and function. This course will familiarize attendees with recent technological advances in the field. Nationally renowned experts in echocardiography, valvular heart disease, and new imaging modalities will present the most up-to-date information, with hands-on demonstrations of basic and advanced Doppler offered on the first and second days. Participants are invited to present cases throughout the conference.
Who Is This Course For?
This course is intended for anesthesiologists, cardiologists, sonographers, and medical professionals who are interested in a comprehensive review of echocardiography and an introduction to the newest advances in the field.
- Fundamental and Advanced Chamber Quantification: ASE Guidelines and Beyond
- Comprehensive Cardiac Hemodynamics
- Advanced Quantitation of Valvular Heart Disease with Case Studies
- Role of 3-D Echo in Assessment of Valvular Heart Disease
- Heart Failure: Acute and Decompensated, Systolic and Diastolic
- The Evaluation of Chest Pain:Coronary Artery and Aortic Disease
- Transesophageal Echocardiography
- Congenital Echocardiography in the Adult
- Practical Workshop on Strain and 3-D Cropping.
- Attend Wednesday afternoon workshops and you will receive a time-limited, fully functional, uploadable version of QLAB as well as important TEE and TTE volumes.
- Echocardiography in 2018 and Beyond
Rebecca T. Hahn, MD, FASE, FACC
NewYork-Presbyterian/Columbia University Medical Center
New York, NY
CME Accreditation and Designation
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this live activity for a maximum of 27.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for registered attendees in exchange for completed activity evaluations. Certificates of attendance are provided to all registered attendees in their meeting materials.
By the end of this course, participants should be able to:
- Apply the ASE Guidelines document for quantification of left and right ventricular size and function using M-mode, 2-dimensional, and 3-dimensional echocardiography, as well as newer modalities such as strain imaging.
- Recognize the criteria for assessing diastolic dysfunction according to the new ASE Guidelines.
- Employ qualitative and quantitative measures to describe the severity of valvular heart disease, including prosthetic valve disease, and apply the current ASE guidelines.
- Know the utility of echocardiography in systolic heart failure diagnosis and therapy, including the new ASE recommendations for the management of ventricular assist devices.
- Describe the echocardiographic and Doppler methods to assess pericardial disease as per the new ASE guidelines.
- Recognize the spectrum of diseases of the aorta and the ASE recommended approaches to the use of imaging for diagnosis and management.
- Identify the utility of stress echocardiography for evaluation of coronary heart disease, dyspnea, and valvular heart disease.
- Recognize the utility of transesophageal and intracardiac imaging in management decisions in the interventional lab, operating room, and intensive care unit.
- Explain the complementary use of other imaging modalities such as CT, MRI, and vascular imaging.
- Recognize the echocardiographic presentation of special patient populations, including those with cancer, congenital heart disease, athletes with heart disease, and heart disease in pregnancy.
Target Audience/Who is this course for?
This course is intended for anesthesiologists, cardiologists, echocardiography technicians, and medical professionals who treat structural heart disease and/or are interested in a general review of echocardiography.
Evaluation will address content, presentation, possible bias, and future educational needs.
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.
Program Sponsorship and Support
This activity is sponsored by the Cardiovascular Research Foundation, Columbia University Medical Center, and Morristown Medical Center. This conference is partially funded through educational grants from commercial supporters.